- Home
- PLX vs HOFT Comparison
PLX vs HOFT Comparison
Compare PLX & HOFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- HOFT
- Stock Information
- Founded
- PLX 1993
- HOFT 1924
- Country
- PLX United States
- HOFT United States
- Employees
- PLX N/A
- HOFT N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- HOFT Home Furnishings
- Sector
- PLX Health Care
- HOFT Consumer Discretionary
- Exchange
- PLX Nasdaq
- HOFT Nasdaq
- Market Cap
- PLX 122.6M
- HOFT 119.9M
- IPO Year
- PLX 1998
- HOFT 1999
- Fundamental
- Price
- PLX $1.37
- HOFT $10.75
- Analyst Decision
- PLX Strong Buy
- HOFT
- Analyst Count
- PLX 1
- HOFT 0
- Target Price
- PLX $15.00
- HOFT N/A
- AVG Volume (30 Days)
- PLX 1.3M
- HOFT 179.1K
- Earning Date
- PLX 08-13-2025
- HOFT 09-04-2025
- Dividend Yield
- PLX N/A
- HOFT 8.40%
- EPS Growth
- PLX N/A
- HOFT N/A
- EPS
- PLX 0.05
- HOFT N/A
- Revenue
- PLX $59,764,000.00
- HOFT $389,210,000.00
- Revenue This Year
- PLX $65.02
- HOFT $1.35
- Revenue Next Year
- PLX $57.34
- HOFT $10.05
- P/E Ratio
- PLX $28.34
- HOFT N/A
- Revenue Growth
- PLX 0.18
- HOFT N/A
- 52 Week Low
- PLX $0.82
- HOFT $7.34
- 52 Week High
- PLX $3.10
- HOFT $19.79
- Technical
- Relative Strength Index (RSI)
- PLX 41.78
- HOFT 49.86
- Support Level
- PLX $1.43
- HOFT $10.82
- Resistance Level
- PLX $1.54
- HOFT $11.29
- Average True Range (ATR)
- PLX 0.09
- HOFT 0.71
- MACD
- PLX 0.01
- HOFT -0.06
- Stochastic Oscillator
- PLX 5.77
- HOFT 36.79
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.